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Abstract
Background: Prescription medicine sharing has been defined as the lending of medicines (giving prescription
medicines to someone else) or borrowing of medicines (being given and using a medicine prescribed for another
person). This qualitative study explored the views of patients, to elicit information regarding factors influencing
medicine sharing behaviours, their experiences of the consequences of prescription medicine sharing, and their risk
assessment strategies when deciding to share.
Methods: One-on-one, face-to-face, semi-structured interviews were carried out in Auckland, New Zealand
between September 2013 and August 2014 with 17 patients, purposively sampled to provide information from
different socio-demographic backgrounds. The interviews were audio recorded, transcribed verbatim and analysed
using a general inductive approach. The study received ethical approval, and all interviewees provided written
informed consent.
Results: Findings were captured within five overarching themes: types of shared medicines; perceived benefits
of sharing medicines; negative experiences of sharing; factors influencing sharing behaviours; and risk assessment
strategies. Participants reported that sharing helped them to avoid treatment costs and the inconvenience associated
with medical visits such as booking appointments. Conversely, unanticipated side effects, allergies, and taking
inappropriate medicines were the main adverse consequences of sharing. Altruism, limited access to medicines/health
services, sociocultural factors, and having unused prescription medicines were factors influencing sharing behaviours.
Participants reported assessing the safety of sharing a medicine primarily based on symptom matching, past illness
experiences, and knowledge about the medicines.
Conclusions: This study enriches previous survey findings, by providing insight into patients' reasons for medicines
sharing. Healthcare providers should consider asking their patients about any medicines they have shared and their future
sharing intentions, in order to use the opportunity for discussing safer sharing practices, without promoting the
behaviour. The findings are helpful for informing the development of potential interventions and targeted educational
messages about safe medicine use for patients.
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Background
Prescription medicine sharing has been defined as the
lending of medicines (giving prescription medicines to
someone else) or borrowing of medicines (being given
and using a medicine prescribed for another person) [1].
Medicine sharing has two distinct types; these are recre-
ational and non-recreational sharing. While recreational
sharing can be defined as the sharing of abusable
prescription medicines “to get high” or feel good, non-
recreational sharing is the sharing of any prescription
medicine for its intended therapeutic benefits. Although
most forms of sharing are non-recreational in nature, [2]
recreational sharing has received most of the research
focus for the previous four decades [3–5]. Limited re-
search evidence is available around non-recreational
sharing; therefore, this study aimed to fill this gap.
While non-recreational sharing is not a new
phenomenon, it has received increasing attention from
researchers, due to its potential medical and public
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health implications [1, 6–16]. Some of these implica-
tions are unmonitored adverse drug events, [6] drug
resistance, [7] complications in clinical diagnosis, [6]
and delay in care seeking [17]. Although borrowers are
at higher risk than lenders, of unexpected side effects
or allergies from shared medicines, [9] lenders could
also deplete their own medicine supply and incur a
risk of therapeutic failure. On the other hand, medicine
borrowing may be beneficial in some instances, for ex-
ample, in an emergency situation. For those who do not
have easy access to health services or are dissatisfied with
healthcare systems, sharing provides an alternative
method for accessing prescription medicines [18–20]. Fur-
thermore, in modern societies, medicines are often part of
an individual’s everyday life and might be shared to restore
ill health or to facilitate social interactions [19].
A range of medicines has been reported to be shared
[1, 8–11, 13, 20–26]; pain medications, allergy medica-
tions, and antibiotics were chief among them [1, 10, 23].
The sharing of asthma inhalers, [20] diabetes medica-
tions, [11] antihypertensives, [8, 10] corticosteroids, [21]
acne medications, [21, 23] and antiretrovirals [25, 26]
has also been reported to be common. Friends and fam-
ily members were the main sources of shared medicines
[1, 8, 23, 27]. Though medicine sharing is frequently re-
ported amongst adults and adolescents, [9, 23] one study
reported that the parental use of a child’s prescribed
medicine for another child also occurs [10]. While this
form of sharing could help to alleviate a child’s illness,
administration of medicines not meant for a specific
child could result in using inappropriate doses, hospital
admission, or death [24].
Although there is no accepted, gold standard method
for assessing medicine sharing, 5–66 % prevalence rates
of sharing have been documented across studies [1, 8, 9,
11, 13–15, 21–23, 27, 28]. Females have been reported
to be more likely than males to lend prescription medi-
cines [1, 21, 23, 27]. In a representative national sample
of 26,566 American adults, age was found to have more
influence than gender on medicine lending or borrowing
behaviour, with the prevalence of lending or borrowing
behaviour increasing as age decreased [23]. Ethnicity
and/or race appear to have less influence on medicine
lending behaviour [29]. Lower income level, [27] un-
employment, [10] larger household size, [10, 27] and
having a chronic disease [21] have been found to be
positive predictors of sharing behaviours, across studies.
On the other hand, one study found that having health
insurance, and a primary care provider who frequently
asked about medicine usage were negatively associated
with the borrowing behaviour of urban medical centre
clients in New York [8].
Several factors have been reported to be reasons for
medicine sharing behaviours. These include running
out of previously prescribed medicine, [1, 10, 11, 23] in-
ability to afford a medical visit or prescription charges,
[8, 11, 13, 27, 30] emergency situations, [1] or conveni-
ence [8]. Being prescribed the same medicine or having
the same health problem as the other person could also
create opportunity for sharing medicines [1, 22]. Although
several reasons contributing to medicine sharing were re-
vealed by the above studies, many of these studies listed
predetermined factors and asked participants to choose
among them, [1, 9, 11, 14, 23, 27] and this process might
limit the identification of a comprehensive range of
motives for sharing from the patient perspective. Overall,
little is known about the psychosocial, behavioural and
cultural factors that influence medicine sharing. It is also
unclear how patients assess the risk of sharing medicines
and if, and how they assess risk in their decision making
to lend/borrow medicines.
Further, previous research around sharing has tended to
take a medical perspective and largely focussed on nega-
tive consequences of sharing behaviours [1, 6, 7, 17]. This
approach may not provide a complete picture of sharing.
People’s decisions to share medicines might not differ
from their decision to share other commodities, [31] and
understanding the ‘social context’ of medicines could pro-
vide further insights into why people share medicines.
The majority of the evidence around adults’ medicine
sharing practices has been from cross-sectional surveys;
limited qualitative studies are available describing non-
recreational medicine sharing behaviours among adults
[12]. A recent, extensive literature search by the research
team has revealed only two qualitative studies that were
specifically designed to assess medicine sharing behaviours
[11, 31]. One of these studies explored older adults’
sharing behaviours, [11] and the other was designed to de-
termine people’s willingness to share medicines in com-
parison with other sharable commodities and, as such did
not provide details about sharing behaviours [31]. Our
study has addressed this gap in the literature. The overall
research process was guided by the central research ques-
tions: “Why do adults lend or borrow prescription medi-
cines" and "How do they decide whether or not to do so?”
These questions seek to understand sharing behaviours
from medical and socio-cultural perspectives. The aims of
the study were: (1) to understand adults’ experiences of
the consequences of prescription medicine sharing; (2) to
identify factors influencing medicine sharing behaviours;
and (3) to understand how patients decide if prescription
medicines are safe to be shared. This study has provided
new information regarding the types of shared medicines,
factors contributing to and potential consequences of
sharing and patients’ medicine sharing risk assessment
strategies. Therefore, the information may help healthcare
providers to identify and address problems related to
medicine sharing. The findings can also be used by patient
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support groups, medicine regulatory agencies, and other
local and international organisations involved in promot-
ing the safe use of medicines.
Methods
Design and sampling
A qualitative approach was adopted for this study. One-
on-one, face-to-face, semi-structured interviews were
conducted to explore adults’ beliefs and experiences
about prescription medicine sharing practices. In this
type of research it is usual to recruit up to 30 partici-
pants or collect data until data saturation is reached,
whichever comes first [32]. Participants were sampled
purposively based on their age, gender, income, and
employment status in order to gather a wide range of
information from different socio-demographic back-
grounds. English-speaking adults aged 18 years or older
with experience or interest in medicine sharing were
eligible to participate. Health-care professionals were ex-
cluded from participation. The interpretation of findings
was guided by a ‘harm reduction’ philosophy focusing on
minimising the risks/harms of sharing without necessar-
ily considering it essential to eliminate sharing practices.
Study setting and recruitment
The study took place in Auckland, the largest city in New
Zealand with a population of 1.4 million [http://www.sta-
tistics.govt.nz/Census/2013-census/profile-and-summary-
reports/quickstats-about-a-place.aspx?request_value=1317
0&tabname=]. Participants were invited through local pa-
tient support group newsletter advertisements, pamphlet
advertisements in a public library and a community phar-
macy, and via email advertisements on university email
lists. When participants approached the researchers, their
eligibility was checked by the first author (K.B.) using a
checklist developed for this purpose.
Data collection
To ensure consistency, all interviews were conducted by
K.B. K.B. is a pharmacist, but not registered to practice
in New Zealand, and this was made known to partici-
pants. An interview guide (see Additional file 1) was
used to ensure broadly similar topics were covered with
each participant whilst allowing them to introduce and
expand upon individual experiences. The selection of
topics was guided by the research team experience and a
review of available literature [1, 8, 13, 16, 17, 23, 27].
The research proposal was also presented at School of
Pharmacy, the University of Auckland, departmental
seminars and feedback received from colleagues was
used to refine the topics. The interview guide was
piloted with two participants and the results discussed
among the research team to further refine the guide.
Pilot data were excluded from final analysis. The main
topics explored in the final guide were: the types of med-
icines shared by participants, participants’ beliefs and
experiences about benefits and adverse consequences of
medicine sharing, circumstances that lead to sharing
medicines, participants’ views regarding ways to minimise
the potential harms of medicine sharing. After conducting
the first four interviews, previously unforeseen topics were
added to the interview guide. Participants also completed
a short questionnaire describing their socio-demographic
characteristics and medicine-taking habits.
Participants were interviewed at a time and location of
their choice. With the exception of one participant (who
preferred to be interviewed at home), all interviews were
conducted at the University of Auckland. To ensure par-
ticipants understood the purpose of the study, all partici-
pants were provided with a general definition of medicine
sharing, and were instructed to focus on non-recreational
prescription medicine sharing. With participants’ consent,
all interviews were audio recorded. At the end of each
interview, the participant was given a document describ-
ing the potential risks of medicine sharing. Interviewing
continued until data saturation was reached, which was
considered to have occurred after 17 interviews (as no
new themes were identified from the last three inter-
views). The mean duration of the interviews was 47 min
(range: 30–72 min), and they were conducted between
September 2013 and August 2014.
Data analysis
After each interview, the interviewer made field notes
and this information was used to describe how each
interview was conducted and to note issues or com-
ments not sufficiently captured by audio recordings.
This information aided interpretation of data. Interviews
were transcribed verbatim by K.B. (n = 6) or an inde-
pendent professional transcriber (n = 11), and the tran-
scripts were checked against the audio recordings by
K.B. All participants were offered an opportunity to edit
their interview transcripts; however, with the exception
of one participant, they did not read and edit them. To
ensure anonymity, names, place of work, or any other
identifying information was removed, and a unique code
number was assigned to each transcript. The data were
analysed using the general inductive approach (GIA)
[33]. GIA is a thematic analysis approach with both
deductive and inductive features. In GIA, while the gen-
eral (or overarching) themes are derived from the re-
search objectives (deductive feature), more specific
categories/themes arise from the data (inductive feature)
[33]. NVivo 10 software (QSR International) was used to
support the analysis process. Before data coding began,
the audio recordings, field notes, and the interview
transcripts were repeatedly revisited by K.B. to identify
salient topics in relation to the research objectives. The
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preliminary findings were also discussed amongst all au-
thors at several meetings held during the course of the
project. Initially, the authors met to agree on the coding
procedure and a coding framework was developed to
guide the process. Then, two of the authors (K.B. and
T.A.) independently coded four, randomly selected inter-
view transcripts, and then all authors met to resolve any
coding discrepancies. The main discrepancy identified
was an overlap between themes; for example, sharing
medicines because of inability to pay for a medical visit
was coded initially both under ‘cost’ and ‘access’ codes,
but later a decision was made to code these data as
‘cost.’ Discrepancies and overlaps were remedied through
mutual consensus among the research team. Afterwards,
the codes from both coders were merged to create an
initial codebook. Using the initial codebook, K.B. coded
the remaining transcripts. The initial codebook was
added to and adapted as the coding process progressed
to incorporate emerging codes. Instead of line-by-line
coding, the coder coded only sections of data meaning-
ful to the research aims. Overall, two levels of coding
were employed. The initial coding phase was used to
reduce large tracts of unorganised data into a more
manageable form based on the general research topic.
The second phase involved more focused coding and
was used to identify themes, patterns and relationships
emerging across the data. The initial and second phase
codes and their text segments were systematically orga-
nised to examine for any similarities or differences in
order to draw conclusions. At this point, patterns and
relationships started to emerge within and among major
themes and sub-themes (see Table 1 for details). Infor-
mation from each interview was compared with other
interviews to elicit variation and to identify similarities
and explain outlying data or negative cases. Mind maps
and diagrams (drawn using Post-It notes and poster
paper) were used to visualise the relationship between
themes and sub-themes. After completion of coding, the
data within each code were re-read and this process
helped to identify and accurately re-code miscoded data
into appropriate categories. The authors then met to dis-
cuss the main findings and to explore alternative inter-
pretations of the findings. Overall, five overarching
themes were identified. These were: types of shared
medicines, perceived benefits of sharing, negative experi-
ences from shared medicines, factors influencing sharing
medicines, and risk assessment strategies.
Results
Participant characteristics
The sample comprised 12 females and five males, with
a mean age of 41.2 years (Range: 23–69 years) and the
majority of participants (n = 10) self-identified as New
Zealand European (see Table 2 for detailed description of
participants’ characteristics). Twelve participants were re-
cruited through email advertisements to the University of
Auckland community, and two each through a public li-
brary and a patient support group. One participant was re-
cruited from a community pharmacy.
Types of shared medicines
A range of medicines was reported to be shared (see
Table 3). Although most of the sharing practice de-
scribed was for medical purposes, sharing for non-
medical purposes was also reported, for example, for
cosmetic use (e.g., Botox®), to relax or to “get high” (e.g.,
strong pain medications), and for dietary supplementa-
tion (e.g., glucosamine). Participants also reported shar-
ing homeopathic preparations which were sometimes
recommended by their GP.
Perceived benefits of sharing medicines
Participants reported a range of benefits and these were
categorised into two sub-themes.
Saves time and money
Participants stated that medicine sharing helped them to
avoid doctors’ fees and prescription charges, and re-
duced the burden associated with medical visits such as
booking appointments, arranging transport, and the
need to visit a pharmacy afterwards. Participants stated
that visiting a doctor often requires taking time off work
and can be costly in terms of income loss or the incon-
venience it can create. Participants also reported sharing
prescription medicines for conditions that require imme-
diate treatment because of long waiting times at busy
surgeries. Sharing also provided participants with easy
access to medicines particularly when they considered
themselves not sick enough to visit a doctor or when
they only required a few doses of the medicine.
For those who were concerned about finances, sharing
provided an opportunity to try the medicine before mak-
ing a decision to pay for a doctor’s appointment. When
the shared medicine was found to be effective, some par-
ticipants visited their doctor to inform them of their
positive experience and obtain their own prescription.
I have psoriasis and I have some friends who have
psoriasis. So if they said to me, “Oh my doctor gave me
this [cream], and it was great.” I might say, “Oh do
you think I could try that a little bit?” I could see
myself doing that. Maybe I’ll see if it seems to work for
me and I’ll go to the doctor and get it myself. (P07, 69-
year-old female)
For some participants, medicine sharing was a way of
preventing wastage of resources. Some considered
discarding unused medicines to be wasteful, and was a
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Table 1 Overview of codes, sub-themes and overarching themes
Codes (specific categories) Code description Sub-theme Overarching theme
Pain, asthma and sleep medications,
antibiotics, and so forth.
Classes of medicines shared by participants NA Types of shared
medicines
Avoid doctor visit Sharing avoids the need to visit a doctor Saves time and money Perceived benefits
of sharing medicines
Avoid hidden costs Sharing avoid taking time off work or avoid inconveniencing
work – avoids hidden cost
To avoid waste To avoid buying a packet when only need one dose or might
not work
Convenience Sharing is more convenient, the medicines are readily
available, no need to visit a GP
Emergency Sharing when someone is in great need of the medication or
during emergency
To try the medicine To see if the medicine works before obtaining a personal
supply
Misplacing medicines Misplacing own medicines and temporarily sharing other’s
medicines
Common minor condition Sharing medicines when the patient perceives that the
medical condition is minor
Caring relationship Sharing is a means of supporting each other during









Adverse drug events Sharing might result in unanticipated side effects, drug
interactions, allergy or contraindications
Expired medicines might be shared Expired medicines might be shared
Risk of killing/harming Sharing may have a risk of killing or harming a person
Topical medicines are weaker than
orally ingested medicines
Sharing topical medicines is not as risky as sharing pills – can
be removed by washing
Loss of medication instruction Lack of information – e.g. borrower does not have information
on risks, adverse outcomes, etc.
Medical condition get worse Sharing complicates simple medical conditions by delaying
diagnosis and treatment
Misdiagnosis Sharing based on misdiagnosis could be dangerous
Unhygienic Sharing medicines (e.g., inhalers) is unhygienic Public health risk
Antimicrobial resistance Sharing might increase drug resistance
Spread infection Sharing creams/ointments might spread the
disease – cross infection




Dependence Sharing might result in drug dependence
To help a friend or family Sharing to help out others or to make someone feel
better – caring relationship
Altruism Factors influencing
medicine sharing
Ran out Ran out of previously prescribed medicines





Access Sharing when difficult to access medicines – for example
prescription restriction and when pharmacy or doctors are
inaccessible or where there is no nearby health facility
Waiting times Sharing medicines to avoid long appointment or waiting
time at GP surgeries
‘After hours’ Sharing for pain occurring late at night or over the weekend –
when a regular GP is not accessible
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reason they were willing to share their unused medi-
cines, as long as they believed them to be of benefit to
someone else. During many of the interviews partici-
pants asked the interviewer if there was any way to re-
turn or donate unused medicines. Also of note, was that
participants considered paying for medical visits to be a
waste of money, when only a few doses of medicine are
required.
Sometimes medicines were lost or misplaced and par-
ticipants borrowed to avoid the inconvenience of getting
a replacement prescription. Sharing also allowed some
participants to avoid the fear of the consequence of
missing a few doses of the medicines they were relying
on (e.g. diabetes medications or asthma inhalers).
Sharing as a form of social support
Apart from cost reduction, medicine sharing had a posi-
tive impact on social interactions. During sharing, par-
ticipants disclosed the nature of their illness to the other
person, and this process helped them to share illness ex-
periences and to sustain and nurture a social relation-
ship. A university student described her boyfriend’s
positive experience as follows:
My boyfriend got a nasal spray [for snoring] from his
friend, that really helped, that really worked, even
brought them closer, because that’s a very special
experience. (P08, 28-year-old female)
Negative experience from shared medicines
Participants described various risks and harms of medi-
cine sharing and these were classified into three sub-
themes. While some participants revealed their own
negative experiences from shared medicines, others pro-
vided hypothetical scenarios to explain the potential
risks of sharing.
Unsafe and ineffective treatment
In an effort to help friends or relatives, participants
engaged in “diagnosing” and “prescribing” which re-
sulted in sharing their medicines with others. How-
ever, in so doing, some of the participants ended up
giving inappropriate medicines to the other person.
According to participants, it is often difficult for an
untrained person to make the correct judgment re-
garding the dosage, potential contraindications, and
side effects as this often requires technical knowledge
Table 1 Overview of codes, sub-themes and overarching themes (Continued)
Traveling Sharing medicine during family trip, holiday trips or when
traveling overseas
Forgetfulness Someone forgets to carry around their own medicines
Leftover medicines Having leftovers/unused medicines creates opportunity for
sharing
Leftover medicines
Lack of information about safe
disposal
Not knowing what to do with leftover or unused medicines
HCPs not mentioning not to share When patients do not receive information from health care
providers about the risk of sharing
Cultural influence Cultural beliefs, family values and customs may influence
medicine sharing
Sociocultural factors
Embarrassment Embarrassment about seeing a doctor or embarrassed to carry
around own medicines
Ads/Internet TV ads or the Internet encourages self-diagnosis and sharing
medicines
Familiarity with the medical
condition or the medicine







Complex medical condition If the condition is complex – deterrent
Uniqueness of medication for the
person
Medicines meant for a specific condition are less likely to
be shared
Unaware of risk Unaware of risk of sharing – facilitator
Perception of efficacy Assuming if the medicine worked for the lender it will do
the same for the borrower
Perceived danger of medicine Concern about side effects – deterrent
Borrower’s responsibility Borrower decides and accepts responsibility for consequences Borrower’s responsibility
Same symptoms Having the same symptoms facilitates sharing Symptoms matching
Same medicines Attitude that taking similar medication as the other person
might not have a negative effect on one’s health
NA not applicable
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about medicines. Sharing can have life threatening
consequences; one of the participants recounted the
negative consequences occurring when her mother
borrowed a medicine.
My mother, she was having pain. She had spondylitis
so she was having severe pain and she was talking to
her friend who is her next-door neighbour. So she said,
“Oh you know what, I have this medicine and it
worked fantastic for me” and she gave my mum, and
she was given a CNS acting drug, she was given [sic]
to take three tablets a day. My mum took the same
dose and she went into coma that night. (P10, 30-year-
old female)
A few incidences of medicine sharing had resulted in
allergic reactions. Most participants believed that the de-
cision to share medicines often relies on symptom
matching alone and that allergy histories might not be
properly assessed. One participant described her nega-
tive experience as follows:
A long time ago my mum and I were in [country], we
were living in a small town, we shared medicine once,
after my mum took the medicine her eyes became
swollen and she stopped the drug, and she went to the
GP, and the GP actually told her that she is allergic to
that kind of drug. (P08, 28-year-old female)
Public health risk
Participants had different opinions regarding the risk of
antibiotic sharing. Some of them had fewer concerns
about sharing antibiotics particularly for common condi-
tions; others were worried about treatment failure and
antimicrobial resistance due to sharing and incomplete
Table 2 Participant characteristics




Age in yearsa (Mean age = 41.2 years,
Range: 23–69 years)
20 - 30 6
31 - 40 2
41 - 50 3
51 - 60 2
60+ 2
Ethnicity
New Zealand European 10
Chinese 4
Others (Indian, Māori, Brazilian) 3
Highest level of education attended
Tertiary education (college and above) 15
Secondary school 2
Working status
Working full time 10




Monthly income (in NZD)a
<1000 2
1001 – 2000 7
2001 – 4000 2
4001 – 6000 2
6000+ 2
Have you been taking any prescription
medicines in the past one year?
Yes 16
No 1
aData were not obtained from two participants
Table 3 Medicines shared by participants
Allergy medications (e.g., e.g., Zetop®, EpiPen®, hay fever medications)




Anti-inflammatory medications (e.g., diclofenac, naproxen)
Asthma inhalers (e.g., Ventolin®, Symbicort® inhaler)
Botox® (cosmetic use)
Cardiovascular medications (e.g., Cartia®, aspirin)
Cholesterol medications (e.g., simvastatin)
Constipation relief medications (e.g., VitoLax®)
Diabetes medications (e.g., metformin, glipizide)
Dietary supplements (e.g., glucosamine tablets)
Gastric/duodenal ulcer medications (e.g., omeprazole, Losec®)
Homeopathic medications
Hypnotics (e.g. nitrazepam, Valium®, melatonin)
Migraine medications (e.g., sumatriptan)
Muscle relaxants
Nasal spray to treat snoring
Nitrous oxide canister
Oral contraceptive pills
Pain medications (e.g. tramadol, morphine, codeine, pethidine)
Psoriasis medications
Topical antifungal/corticosteroids (e.g., Micreme H®, Betnovate®, eczema
medications)
Beyene et al. Journal of Pharmaceutical Policy and Practice  (2016) 9:23 Page 7 of 13
courses of antibiotics. Depleting one’s own supply and in-
effective treatment were other risks mentioned by those
who had concerns about antibiotic sharing.
Sharing some forms of medicines (e.g. eye drops,
asthma inhalers, creams or ointments) was considered
by participants to be unhygienic and a way of spreading
infections. Apart from the spread of infections, it
appeared that participants had fewer concerns about the
effects of some of these medicines. For instance, many
participants were less concerned about the possible side
effects or toxicity from shared creams or ointments,
compared to pills. On the other hand, one participant
warned that the likelihood of exacerbating skin condi-
tions when using inappropriate creams could be high,
and she explained the common misconceptions towards
topical preparations amongst the public.
We think it’s safer because we don’t take it in and
that’s less chance of getting poisoned by it or
something. It’s probably not, that’s what people think.
If you eat it inside then people take more precautions.
Whereas if it’s topical like something on the skin, like if
it’s a cut or a burn or something then they just think
it’s less important than something that’s happening
inside. (P16, 29-year-old female)
Risk of drug dependence
Participants also discussed about the impact of medicine
sharing on drug dependence. Participants stated that al-
though sharing by itself might not necessarily result in
drug dependence, some medicines (e.g. strong pain med-
ications) might be shared for thrill-seeking. Participants
believed that this form of sharing could have a negative
impact on social relationships. A participant who had
been prescribed these medicines described strategies he
uses to minimise the chance of being a source of abus-
able medicines, such as keeping social distance or con-
cealing information from potential abusers.
If they [drug abusers] knew what I had [strong pain
killers] they would be knocking at my door, “bro can I
have a few of these, few of that?” So that’s why I tell
them nothing because I know what they use them for.
(P11, 50-year-old male)
Factors influencing medicine sharing
Participants reported many factors that could facilitate
prescription medicine sharing practices; these were clas-
sified into four sub-themes.
Altruism
A desire to help others (i.e. altruism) was often the main
motivator for those who reported sharing medicines.
They shared their medicines for what they perceived to
be a good reason, to help their loved ones when they
were suffering from an illness. Participants’ past illness
experience could further encourage altruistic behaviour.
This was described by one of them.
Just someone here at work had a terrible migraine and
the person did not have access to medication, you know,
and it’s something that I suffer from migraine and I know
how horrible it is so I just said look I have sumatriptan
here, if you want I can give you. (P12, 41-year-old male)
Although medicines were more often reported to be
shared with family members, close friends, neighbours,
or work mates, when it came to helping people in urgent
need of medicine, social distance was less important.
Yes, one time actually, my boyfriend has asthma and I
had his inhaler in my bag because I always carry
around for him, and I was out in the pub and a guy
had really bad asthma and his friend was running
around and saying “Inhaler, inhaler”, so I gave him, so
yeah, I did do that, I am happy to do it, it was not like
an emergency, but he definitely needed the inhaler.
(P09, 25-year-old, female)
Sometimes the lender used the sharing instance as an op-
portunity to establish a friendship with the borrower, al-
though the main motivator, in doing so, was often altruism.
I get anxious so I take omeprazole or Losec®. … And if
somebody told me that their stomach was hurting and
they needed one of those, I would do that [share], sure.
I’m trying to be friendly and a bit of a socialist, you
know (laughs), but I don’t do it to save money. (P07,
69-year-old female)
Limited access to medicines/health services
The cost of medical visits hindered participants with
limited resources from seeking medical care and being
prescribed their own medicines. Some of them revealed
that their health insurance was limited and did not cover
all their medical needs, for example, students and retired
participants. Limited opening hours of local pharmacies
and surgeries also influenced participants’ sharing behav-
iours. For instance, participants reported sharing medi-
cines for pain occurring late at night or at the weekend
when local health facilities were not accessible. A univer-
sity student associated her medicine sharing behaviour
with the campus clinic opening hours as follows;
My health insurance is very limited, for example, it’s
only free if I go to the campus clinic, and the campus
clinic you need to book and their opening hours is very
short, I think they are closed at 3:00 PM or 4:00 PM. So
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it will be easier if I just get the medicine from someone I
know and solve my problem. (P08, 28-year-old female)
Participants also reported sharing medicines while
travelling when they could not access their regular doc-
tor within a reasonable time.
Sociocultural factors
Social, cultural, and interpersonal interactions influen-
cing participants’ sharing behaviours were captured by
this theme.
Although not nationally representative, participants
were drawn from different communities, and it was
noted that for some participants (e.g. those recently mi-
grating to New Zealand) visiting a doctor and getting
their own medicines was not an easy experience, partly
because of cultural differences (e.g. communication bar-
riers or differences in the health systems). Those partici-
pants considered medicine sharing to be a means of
accessing prescription medicines without having to see a
GP. It was also revealed that in some cultures sharing
medicine and other commodities is a way of providing
social support for others. One participant had lived in
New Zealand for a number of years. He described the
difference in perspectives about sharing medicines and
the role of medicines, between people from his home-
land and New Zealanders, as follows;
In New Zealand it’s not culturally acceptable, you
don’t share someone else’s drink whereas back home it
is quite common so I guess that cultural difference
may come into play.… [people from his homeland] are
much more interventionist they will medicate people
much more commonly than in New Zealand. So back
home, I think there’s much more medication sharing
than in New Zealand. (P12, 41-year-old male)
Embarrassment was reported as a major reason why
some patients do not visit their GP to obtain their own
prescriptions. Participants also believed that younger pa-
tients might be embarrassed to carry around medicines
they rely on and need to take in front of others (e.g.,
asthma inhalers) because doing so might be considered,
by peers to be an indication of weakness.
Participants believed that advertising medicines on
television might encourage people to self-diagnose and
borrow medicines. It was noted by participants that
when a prescription medicine is advertised on television
it may lead the public into believing that the advertised
medicine is safe to be shared, and might change their at-
titude towards the risks associated with sharing it. Youn-
ger participants appeared to be more influenced to
share medicines by patient fora and various drug infor-
mation sources on the Internet. One of the younger
participants reported surfing the Internet to help her
decide whether to take the medicine she had been of-
fered by a friend.
I remember once I had a cat bite, the cat got some
fungus infection and I got the infection on my skin as
well. I talked to some friends who also had a cat and I
asked whether they had this kind of problem as well,
and yeah she said she had once a cat bite and she still
have the ointment. So I Googled the drug and I
thought that it suits my condition and I borrowed
from her, and I just used it until the infection was
gone, until I recovered. (P08, 28-year-old female)
Having leftover/unused prescription medicines
Participants were unsure what to do with unused medi-
cines and many of them mentioned passing their unused
medicines on to others. Most of the participants revealed
that they received little information from healthcare pro-
viders about the safe disposal of leftover medicines.
Some participants criticised their doctors for failing to
understand their actual need and for supplying them
surplus pills. A retired woman with back pain was
among those who were unhappy with their doctor’s pre-
scribing behaviour.
Sometimes I have a really bad back problem and so
for a little while I went to a back person [doctor] and
I think they’re very negligent. He gave me a million
tramadol, you know, it was like so much and they just
give you these giant prescriptions and so I don’t think I
would share that tramadol. To me I would put that
into a more serious; it’s not like an aspirin. (P07, 69-
years-old female)
Although the above participant did not share her
tramadol this was not the case for all participants. Some
of them reported sharing their spare medicines (e.g. anti-
biotics), and they believed that having an oversupply of
medicines motivated them to do so.
Risk assessment strategies
Participants reported different strategies that helped them
to assess whether it was safe for them to share medicines
and these were classified into three sub-themes.
Experience of, and knowledge about illness and its treatment
Their own experience with the medicine also helped par-
ticipants to assess risks of sharing. If participants had
been taking the medicine and if they knew what it was
for and were confident that it could help the other per-
son, they were more likely to share the medicine. On the
other hand, if participants thought that their medicines
were specific to their condition, if they were unfamiliar
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with the medicine or when they were not confident
enough about the borrower’s medical condition they
were less likely to share.
Knowledge about illness and its treatment could also
play a significant role in decisionmaking. For example,
those who were aware of the risk of misdiagnosis of
bacterial infections, risk of allergy and/or antimicrobial
resistance firmly opposed sharing oral antibiotics. How-
ever, most participants were unaware of the potential
risks of topical antimicrobials and were willing to share
them. Although the meaning of ‘complicated condition’
was different among participants, they were also gener-
ally uncomfortable with sharing medicines which are
meant for conditions such as cancer, diabetes, heart
problems, or hypertension.
Friends’ positive experiences with a medicine and
obtaining the medicine from a trusted person (i.e., a per-
son with good knowledge of medicine or who used it for
long time) also had an influence on participants’ deci-
sions to borrow medicines.
Borrower’s responsibility
Some participants were not concerned about assessing
risks when lending medicines. They believed that they
were not qualified to diagnose the borrower’s condition
or to assess the risk of the medicine. Further, they stated
that it is up to borrowers to decide if the medicine suits
their condition and/or to check allergic reactions.
I assumed that he didn’t have any sort of particular
allergies or something towards the chemical but I think
it’s not up to the person who’s offering the medicine to
diagnose the other person and give him the right drugs.
It’s just I have this, maybe you want to try it, maybe you
don’t – I don’t really care. (P14, 23-year-old female)
Symptoms matching
Symptoms matching was another strategy used by par-
ticipants to assess the possible risks of sharing medi-
cines. Participants believed that if someone had similar
symptoms to the other person then the medicine would
most probably work for him/her and be safe. Partici-
pants also frequently reported that they would be willing
to try a medicine which worked for their friends with a
similar condition to see if it would also work for their
condition.
Discussion
This research explored the positive and negative conse-
quences of, and factors influencing non-recreational
medicine sharing practices of adults. Furthermore, the
study examined factors considered by patients when de-
ciding to share a medicine. These findings advance our
understanding of non-recreational medicine sharing and
provide further insights into the social, cultural, eco-
nomic, and therapeutic aspects of medicine sharing. Al-
though the potential risks of medicine sharing are well
known to researchers [21, 22, 27] and regulatory authorities,
[http://www.fda.gov/RegulatoryInformation/Legislation/
FederalFoodDrugandCosmeticActFDCAct/] the non-
medical aspects of sharing have been largely unexplored.
From the medical perspective, medicine sharing is often
considered to be undesirable behaviour [6, 17]. However,
patients often see their sharing practices as positive and
the study indicates that they often have sound justifica-
tions for doing so, as described in our findings.
In line with other research, a wide range of medi-
cines were reported to be shared [1, 8–11, 13, 14,
21–23]. A number of previously unreported medicines
were also reported; these include melatonin, muscle
relaxants, Botox®, homeopathic preparations, and mi-
graine medications.
With the rising cost of health-care, it has been noted
that patients with lower incomes may adopt different cost-
coping strategies such as intentional non-adherence, in-
creasing debt burden, or cutting back (or economising) on
necessities such as clothes and food [34]. Our findings
suggest that medicine sharing may be another coping
strategy. This finding is also in line with earlier studies
reporting financial hardship as a reason for medicine
sharing and underutilisation of available health-care ser-
vices [19, 20, 30]. Also of note, in some developing coun-
tries the prevalence rates of medicine sharing are high
(55–66 %) [14, 28] when compared with reports from
developed countries (5–27 %) [1, 8, 10, 11, 23].
For most participants, medicine sharing was not a
major concern. Some participants did not perceive their
medicine sharing to be risky. Instead, they weighed up
the risks and benefits of sharing particular medicines
primarily based on their previous illness experiences and
symptoms matching. In most instances, participants did
not disclose the medicines they have shared or their
sharing intention to healthcare providers; one possible
explanation for this could be a fear of upsetting their
healthcare providers. Overall, participants described a
multifaceted system for determining the safety of the
medicines they had shared. It appears that medicine
sharing practices described in this study sample often in-
volved a thoughtful decision making process rather than
irresponsible behaviour or ignorance. However, although
sharing medicines had many benefits for participants, we
are concerned by some forms of sharing. For instance,
opioid painkiller effectiveness for non-cancer chronic
pain is controversial, [35] and its continuous use may di-
minish pain threshold levels or lead to substance use
disorders [36]. Antibiotic sharing practices might result
in therapeutic failure and may contribute to the emer-
gence of antimicrobial resistance [1].
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Van der Geest et al., in their anthropological study of
pharmaceuticals, pointed out that medicines can be
exchanged between individuals to facilitate social inter-
actions [37]. The authors further noted that medicines
are representations of ideologies and lifestyle. Our study
findings support this; we found that “prescribing” for
others and medicine sharing were common practices,
and these practices had a positive impact on partici-
pants’ social relationships. Many of the participants had
been offered medicines by friends or relatives for free,
and the sharing decision appeared to be influenced by
altruistic reasons rather than the expectation of a re-
ward. Therefore, any efforts to design interventions need
to consider sharing behaviours within the context of
wider social interactions.
Inconvenience, and embarrassment about seeing a
doctor were other reasons why some participants shared
medicines. This may be a coping strategy by patients in
response to a healthcare system that does not address
their needs and expectations. Language, cultural barriers
and a lack of information about the healthcare system
were reported to be contributing factors to poor access
to health services and medicine sharing practices
amongst immigrants in New Zealand [38] and elsewhere
[39]. Similarly, immigrants in this study reported chal-
lenges they have faced in accessing medicines or health
services (such as limited health insurance, an inability to
pay doctors’ fees, and language barriers), particularly
upon their arrival in New Zealand, and the contribution
of those challenges towards medicine sharing practices.
Providing more information for migrants on the health-
care system and using translators in healthcare facilities
were suggested as strategies to reduce some of the prob-
lems mentioned [38].
This study also revealed that some participants initially
try to self-medicate their problems with borrowed medi-
cines before visiting their doctor. This behaviour might
lead to a delay in clinical diagnosis and an increase in
complications from simple conditions [6]. Moreover, if
patients do not inform their prescribers they might be
unaware of the patient’s sharing practices, and as a result
they may prescribe medicines that should not be taken
with the medicine the patient has borrowed [8]. Sharing
unused/leftover medicines is also concerning. Some of
these medicines might have passed their expiry date and/or
their active ingredient might have deteriorated due to un-
favourable storage conditions. Providing systems/pathways
for unused/unwanted medicines to be safely disposed of
(e.g. promoting collection of unused medicines by pharma-
cies) and prescribing medicine in quantities tailored to the
actual need of the patient is more likely to reduce the
amount of leftovers and associated sharing practices. Some
of the adverse reactions reported by participants are poten-
tially life threatening. However, no study to date has tracked
the extent and severity of adverse drug reactions occurring
as a result of shared medicines, and this is an important
area for future research.
Overall, the findings indicate that some individuals are
sharing 'high risk' medicines and this suggests the im-
portance of incorporating questions assessing medicine
sharing behaviours into prescribing, dispensing and
medicine reconciliation activities. Available electronic
medication records can assist in the process of identify-
ing individuals sharing medicines. Posters and leaflets
which show the potential risks of sharing medicines
could be used to increase risk awareness. In addition,
non-compliance with medication regimens is likely to
increase the amount of leftover medicines, thus adher-
ence counselling is crucial to reduce the opportunity for
sharing.
This study is not without limitations and the findings
should be interpreted in the light of these. Participants
were not a representative sample of New Zealand adults,
and thus their views may not be generalisable, although
care was taken to recruit a sample from a broad range of
backgrounds. This could potentially limit the transfer-
ability of findings. Those who could not speak English
were excluded from the study. These individuals are
more likely to have different cultural backgrounds and
they might have unique concerns and expectations re-
garding their health and medicine sharing, particularly
as language and communication barriers are more likely
to increase medicine sharing.
As the professional qualification of the interviewer was
made known to all participants, and it is possible that
such information could have potentially influenced par-
ticipants’ responses. For example, some participants
might believe that sharing medicines is not condoned by
some health professionals and may not have wanted to
disclose the nature of some of their sharing practices to
the interviewer. To minimise the potential for such so-
cial desirability bias, all interviewees were informed of
the general purpose of the research and the measures
taken to ensure confidentiality of information. They
were further informed that there was no right or wrong
answer to any of the questions. This appeared to put
participants at ease. In some interviews the interviewer
was challenged by participants to give his opinion on
topics such as the possibility of sharing medicines in
some instances and legal issues related to medicine
sharing. However, such opinions were not supplied,
except in instances where further explanation was sought
relating to the intention of the interview questions. The
study authors are pharmacists, and despite acknowledging
both the benefits and harms of this practice, this could
have influenced the study design and data interpretation.
However, attention was paid to providing balanced per-
spectives. Lastly, the fear of punishment from a previous
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‘bad’ experience about medicine sharing may have exclude
some individuals from participation.
Limitations aside, this study revealed that medicine
sharing is a behaviour more complex than some previous
quantitative studies suggest. Accordingly, the findings
have important implications for healthcare providers who
regularly engage in patient consultations about the safe
use of medicines and for future research on medicine use
behaviours. A cross-sectional survey among larger cohorts
is currently being conducted by the authors to examine
the extent to which each identified factor influences
patients' medicine sharing decisions, and the relationships
between these factors.
Generally, as noted by Shoemaker and Ramalho de
Oliveria, understanding medicine use behaviours re-
quires carefully analysis of patients’ perspectives and
should not rely only on health professionals’ perspectives
[40]. Thus, taking into account how patients understand
medicine sharing is critical in designing effective inter-
ventions to reduce harms from this practice.
Conclusions
This study enriches previous survey findings, by provid-
ing insight into patients’ reasons for medicines sharing.
For example, altruism, forgetfulness, cost of GP visits,
illness denial and embarrassment, lack of awareness
regarding the risk of sharing, which have received little
attention in previous surveys, were identified as import-
ant factors influencing sharing behaviours. Health care
providers need to be aware that the sharing of prescrip-
tion medicines is not uncommon. The authors suggest
that healthcare providers consider engaging patients in
discussions which may provide further insights into fac-
tors influencing sharing behaviours for particular indi-
viduals. Overall, it might be impractical to stop people
from sharing their prescribed medicines (and even un-
desirable under some circumstances), and minimising
the potential risks/harms of sharing should, therefore, be
a priority whilst also acknowledging the meaning such
behaviours have for patients, and their reasons for shar-
ing. Quantitative research is required to examine the ex-
tent to which the identified factors related to sharing
influence patients’ decisions to share.
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